Thrombolytic therapy remains the predominant reperfusion strategy for ST segment elevation myocardial infarction (STEMI) in the UK, with government policy directed towards optimising thrombolytic delivery. However, the publication of the first Myocardial Infarction National Audit Project (MINAP) report last year informed us that only 28% of hospitals supplying data treated the target 75% of eligible patients inside 30 minutes.
Isn’t it time for primary angioplasty in the UK?
September 2003Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 66–AIC 70 Leave a commentClick any image to enlarge
